Nebulizer Use in Bronchitis Treatment

Introduction to Nebulizer Therapy

Nebulizers are primarily used in bronchitis to deliver bronchodilators, mucolytics, and occasionally antibiotics directly to the airways when hand-held inhalers are insufficient or when patients cannot effectively use them 1, 2

Beta-agonists such as salbutamol and anticholinergics such as ipratropium bromide are commonly used to relieve bronchospasm, as recommended by the European Respiratory Society 1, 2
Hypertonic saline (3%) is recommended for patients with bronchiectasis or chronic bronchitis with viscous secretions to improve mucociliary clearance, typically administered before airway clearance techniques, according to the American Thoracic Society 3
Steroids, such as budesonide, may be used in some cases, as suggested by the British Thoracic Society 1
Antibiotics may be used in specific cases such as bronchiectasis, though less common than in cystic fibrosis, as stated by the European Respiratory Society 1, 4

Nebulizers are preferable to hand-held inhalers when large drug doses are needed for symptom control, as recommended by the American College of Chest Physicians 1, 2
Controlled coordinated breathing is difficult, such as in acute exacerbations, as noted by the European Respiratory Society 1
Hand-held inhalers have been found ineffective despite proper technique, as stated by the British Thoracic Society 1, 2

Use a compressor as the driving gas source, with a flow rate of 6-8 L/min to nebulize particles to 2-5 μm diameter for optimal deposition in small airways, as recommended by the American Association for Respiratory Care 2
Volume of fluid in the nebulizer chamber is typically 2.0-4.5 mL, as suggested by the European Respiratory Society 2

Masks are better for acutely ill patients when holding the nebulizer is tiring or for those who have difficulty with coordination, as recommended by the American Thoracic Society 2
Mouthpieces should be used for nebulized steroids to prevent facial deposition and for antibiotics to allow filter use, as stated by the European Respiratory Society 2

Hypertonic saline is typically administered at a 3% concentration, once or twice daily before airway clearance techniques, as recommended by the American College of Chest Physicians 3

When multiple medications are needed, follow the sequence: bronchodilator, hypertonic saline, airway clearance techniques, and then nebulized antibiotics and/or inhaled steroids, as suggested by the European Respiratory Society 3

Wash mouthpiece/mask and nebulizer chamber in warm water with detergent, rinse thoroughly and dry well after each use, or at minimum once daily, as recommended by the American Association for Respiratory Care 1
Replace disposable parts every three months, or annually if long-lasting type, as stated by the European Respiratory Society 1

Avoid using water as a diluent as it may cause bronchoconstriction when nebulized, as warned by the American Thoracic Society 2
For patients with bronchiectasis, an "n of one" trial is recommended to determine if nebulized therapy is beneficial in their specific case, as suggested by the European Respiratory Society 4
In most cases, hand-held inhalers with proper technique are as effective as nebulizers, making nebulizers primarily indicated for specific situations, as noted by the European Respiratory Society 5, 6

Acute bronchitis: Nebulizers may be used for short-term symptom relief, particularly in patients with underlying respiratory conditions, as recommended by the American College of Chest Physicians 1, 2
Chronic bronchitis/COPD: Regular assessment is needed to determine continued benefit, as stated by the European Respiratory Society 6
Bronchiectasis: Recommendations for cystic fibrosis apply, though with less experimental evidence of benefit; individualized "n of one" trials are recommended, as suggested by the European Respiratory Society 4